122 related articles for article (PubMed ID: 9708865)
1. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats.
Mao J; Price DD; Lu J; Mayer DJ
Neurosci Lett; 1998 Jul; 250(3):193-6. PubMed ID: 9708865
[TBL] [Abstract][Full Text] [Related]
2. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
3. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
4. Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice.
Zushida K; Kamei J
Eur J Pharmacol; 2002 Jul; 448(1):39-44. PubMed ID: 12126969
[TBL] [Abstract][Full Text] [Related]
5. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
6. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
7. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
8. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.
Aley KO; Levine JD
J Neurosci; 1997 Oct; 17(20):8018-23. PubMed ID: 9315920
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
Mjanger E; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
[TBL] [Abstract][Full Text] [Related]
12. DAMGO-induced μ opioid receptor internalization and recycling restore morphine sensitivity in tolerant rat.
Ma X; Chen R; Huang M; Wang W; Luo L; Kim DK; Jiang W; Xu T
Eur J Pharmacol; 2020 Jul; 878():173118. PubMed ID: 32320702
[TBL] [Abstract][Full Text] [Related]
13. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
Paronis CA; Woods JH
Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
[TBL] [Abstract][Full Text] [Related]
14. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
[TBL] [Abstract][Full Text] [Related]
15. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
16. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Aley KO; Green PG; Levine JD
J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats.
Aley KO; Levine JD
J Neurosci; 1997 May; 17(10):3907-12. PubMed ID: 9133408
[TBL] [Abstract][Full Text] [Related]
18. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
19. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
20. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]